{"id":131153,"title":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T10:51:00.212000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/51607.html","snippet":"DSEN Abstract: How does real world use of insulin glargine compare to NPH insulin in terms of effectiveness and safety for the management of type 1 diabetes mellitus (T1DM)? - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services Departments Language selection…","rawSnapshotUrl":"/api/snapshots/raw/131153","browseUrl":"https://replay.healtharchive.ca/job-2/20250410105100/https://cihr-irsc.gc.ca/e/51607.html#ha_snapshot=131153","mimeType":"text/html","statusCode":200}